Genomictree Inc. (KOSDAQ:228760)
17,690
-60 (-0.34%)
Apr 29, 2026, 2:38 PM KST
Genomictree Revenue
In the year 2025, Genomictree had annual revenue of 3.76B KRW with 59.17% growth. Genomictree had revenue of 825.62M in the quarter ending December 31, 2025, with 0.14% growth.
Revenue
3.76B
Revenue Growth
+59.17%
P/S Ratio
115.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
434.87B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SillaJen | 9.23B |
| Helixmith | 2.60B |
| GC Cell | 165.52B |
| Anterogen.Co.,Ltd. | 7.54B |
| BINEX | 168.47B |
| HLB Therapeutics | 69.56B |
| GC Corp. | 2,451.48B |
| Medy-Tox | 247.29B |